Skip to content
Riskpilot
← Back to search
Sign in
Get full access
STIFTELSEN TIL FREMME AV FORSKNING PÅ HJERTE-, KAR- OG LUNGESYKDOMMER, INKLUSIVE KREFTSYKDOMMER
STI
Active
Org 976893050
Activities of other membership organisations n.e.c.
· NACE 9499
Est. 1996 · 29 years old
0 employees
www.unifor.no
Monitor
Share
Norway
/
Companies
/
Activities of other membership organisations n.e.c.
/
STIFTELSEN TIL FREMME AV FORSKNING PÅ HJERTE-, KAR- OG LUNGESYKDOMMER, INKLUSIVE KREFTSYKDOMMER
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
1M
2M
3M
5M
2M
2020
3M
2021
2M
2022
3M
2023
4M
2024
EBITDA
NOK millions
5M
3M
1M
-1M
-3M
2M
2020
3M
+50%
2021
-2M
-167%
2022
3M
+250%
2023
4M
+33%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 042
2 575
2 251
3 309
3 635
Staff expenses
−0
−0
−0
−0
−0
EBITDA
1 984
2 516
−2 312
3 244
3 566
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
1 984
2 516
−2 312
3 244
3 566
Net financials
−232
−139
−173
−214
−247
Profit before tax
1 752
2 377
−2 485
3 030
3 320
Tax
−0
−0
−0
−0
−0
Net profit
1 752
2 377
−2 485
3 030
3 320
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
17 390
19 881
17 281
20 421
23 630
Equity
17 390
19 766
17 281
20 311
23 630
Long-term debt
0
0
0
0
0
Short-term debt
0
115
0
110
0
Total debt
0
115
0
110
0
Financial ratios
5-year trend
EBITDA margin
98.1%
This company
15.8%
Market median
+521% vs market
2020
2024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2020
2024
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
2020
2024
Net profit margin
91.3%
This company
8.1%
Market median
+1027% vs market
2020
2024
Asset turnover
0.15×
This company
1.12×
Market median
-87% vs market
2020
2024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on STIFTELSEN TIL FREMME AV FORSKNING PÅ HJERTE-, KAR- OG LUNGESYKDOMMER, INKLUSIVE KREFTSYKDOMMER
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
